Medifast Inc (MED) stock
MEDNYSEMiscellaneous Food Preparations & Kindred ProductsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 26, 2026Score 10/3064% below fair value
$12.97+0.11 (+0.86%)
Close on Nov 13, 2026Market cap $145.04MP/E –Yield 0.00%
Medifast ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Medifast's ebitda for the twelve months ending Sep 30, 2026 was -$22.03M, down 366.6% year over year. For fiscal 2025 it was $29.00K, down 99.8% from the year before. Over ten years it grew -50.9% a year on average. The highest annual figure on record is $223.05M in fiscal 2021.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $29.00K | -99.8% |
| FY2024 | Dec 31, 2024 | $15.59M | -88.8% |
| FY2023 | Dec 31, 2023 | $139.51M | -28.7% |
| FY2022 | Dec 31, 2022 | $195.79M | -12.2% |
| FY2021 | Dec 31, 2021 | $223.05M | +61.1% |
| FY2020 | Dec 31, 2020 | $138.48M | +44.8% |
| FY2019 | Dec 31, 2019 | $95.66M | +30.2% |
| FY2018 | Dec 31, 2018 | $73.50M | +67.6% |
| FY2017 | Dec 31, 2017 | $43.84M | +35.9% |
| FY2016 | Dec 31, 2016 | $32.26M | -9.9% |
| FY2015 | Dec 31, 2015 | $35.80M | -6.5% |
| FY2014 | Dec 31, 2014 | $38.30M | -17.3% |
| FY2013 | Dec 31, 2013 | $46.31M | +30.4% |
| FY2012 | Dec 31, 2012 | $35.53M | -0.6% |
| FY2011 | Dec 31, 2011 | $35.73M | -4.7% |
| FY2010 | Dec 31, 2010 | $37.50M | +57.8% |
| FY2009 | Dec 31, 2009 | $23.76M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$17.00M | – |
| Q2 FY2026 | Jun 30, 2026 | -$881.00K | -129.6% |
| Q1 FY2026 | Mar 31, 2026 | $188.00K | -90.7% |
| Q4 FY2025 | Dec 31, 2025 | -$4.34M | -211.4% |
| Q3 FY2025 | Sep 30, 2025 | -$629.00K | -111.9% |
| Q2 FY2025 | Jun 30, 2025 | $2.98M | – |
| Q1 FY2025 | Mar 31, 2025 | $2.02M | -82.0% |
| Q4 FY2024 | Dec 31, 2024 | $3.89M | -67.6% |
| Q3 FY2024 | Sep 30, 2024 | $5.30M | -81.7% |
| Q2 FY2024 | Jun 30, 2024 | -$4.81M | -111.4% |
| Q1 FY2024 | Mar 31, 2024 | $11.20M | -80.2% |
| Q4 FY2023 | Dec 31, 2023 | $12.03M | -66.2% |
| Q3 FY2023 | Sep 30, 2023 | $28.92M | -43.3% |
| Q2 FY2023 | Jun 30, 2023 | $42.07M | -18.6% |
| Q1 FY2023 | Mar 31, 2023 | $56.49M | -1.8% |
| Q4 FY2022 | Dec 31, 2022 | $35.55M | -28.7% |
| Q3 FY2022 | Sep 30, 2022 | $51.01M | -9.7% |
| Q2 FY2022 | Jun 30, 2022 | $51.70M | -17.6% |
| Q1 FY2022 | Mar 31, 2022 | $57.53M | +6.7% |
| Q4 FY2021 | Dec 31, 2021 | $49.88M | +34.7% |
| Q3 FY2021 | Sep 30, 2021 | $56.49M | +21.9% |
| Q2 FY2021 | Jun 30, 2021 | $62.76M | +109.8% |
| Q1 FY2021 | Mar 31, 2021 | $53.92M | +114.0% |
| Q4 FY2020 | Dec 31, 2020 | $37.03M | +103.1% |
| Q3 FY2020 | Sep 30, 2020 | $46.34M | +109.9% |
| Q2 FY2020 | Jun 30, 2020 | $29.92M | +3.0% |
| Q1 FY2020 | Mar 31, 2020 | $25.19M | -4.3% |
| Q4 FY2019 | Dec 31, 2019 | $18.23M | -12.0% |
| Q3 FY2019 | Sep 30, 2019 | $22.07M | +20.6% |
| Q2 FY2019 | Jun 30, 2019 | $29.04M | +59.1% |
| Q1 FY2019 | Mar 31, 2019 | $26.32M | +62.2% |
| Q4 FY2018 | Dec 31, 2018 | $20.72M | +97.5% |
| Q3 FY2018 | Sep 30, 2018 | $18.30M | +61.7% |
| Q2 FY2018 | Jun 30, 2018 | $18.26M | +47.8% |
| Q1 FY2018 | Mar 31, 2018 | $16.23M | +67.5% |
| Q4 FY2017 | Dec 31, 2017 | $10.49M | +34.4% |
| Q3 FY2017 | Sep 30, 2017 | $11.32M | – |
| Q2 FY2017 | Jun 30, 2017 | $12.35M | – |
| Q1 FY2017 | Mar 31, 2017 | $9.69M | – |
| Q4 FY2016 | Dec 31, 2016 | $7.81M | – |
See a number that looks wrong?